ACT-01

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameACT-01
Drug Alias NameACT-01OCS-05BN-201G-79
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInsulin-like growth factor I stimulantsBrain-derived neurotrophic factor agonists
TargetsInsulin-like growth factor IBrain-derived neurotrophic factor
Therapy Area/IndicationsOptic NeuritisKeratosis, Actinic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPromius Pharma
China Registration ClassN/A

Develop Information

Active CompaniesOculisEuropean Biotech Acquisition Corp
Inactive CompaniesPromius Pharma Llc
Active IndicationsOptic Neuritis
Inactive IndicationsKeratosis, Actinic

Other Information

ATC CodeN/A
Related LinksN/A